Bryan M. McCauley

ORCID: 0000-0003-4014-2663
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer-related molecular mechanisms research
  • Ovarian cancer diagnosis and treatment
  • Ferroptosis and cancer prognosis
  • Liver Diseases and Immunity
  • Epigenetics and DNA Methylation
  • Liver Disease Diagnosis and Treatment
  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics
  • Genetic Associations and Epidemiology
  • Pediatric Hepatobiliary Diseases and Treatments
  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers
  • Breast Lesions and Carcinomas
  • Gene expression and cancer classification
  • Gallbladder and Bile Duct Disorders
  • Cancer Research and Treatments
  • Breast Cancer Treatment Studies
  • Endometrial and Cervical Cancer Treatments
  • Advanced Biosensing Techniques and Applications
  • Immune Cell Function and Interaction
  • Single-cell and spatial transcriptomics
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Blood Coagulation and Thrombosis Mechanisms
  • Renal cell carcinoma treatment
  • Atherosclerosis and Cardiovascular Diseases

Mayo Clinic in Arizona
2017-2025

Mayo Clinic
2016-2025

Mayo Clinic in Florida
2017-2024

University of Illinois Urbana-Champaign
2022

WinnMed
2022

Ellen L. Goode Matthew S. Block Kimberly R. Kalli Robert A. Vierkant Wenqian Chen and 94 more Zachary C. Fogarty Aleksandra Gentry‐Maharaj Aleksandra Tołoczko Alexander Hein Aliecia L. Bouligny Allan Jensen Ana Osório Andreas D. Hartkopf Andy Ryan Anita Chudecka-Głaz Anthony M. Magliocco Arndt Hartmann Audrey Jung Bo Gao Brenda Y. Hernandez Brooke L. Fridley Bryan M. McCauley Catherine J. Kennedy Chen Wang Chloe Karpinskyj Christiani Bisinoto de Sousa Daniel Guimarães Tiezzi David L. Wachter Esther Herpel Florin‐Andrei Taran Francesmary Modugno Gregg Nelson Jan Lubiński Janusz Menkiszak Jennifer Alsop Jenny Lester Jesús García-Donás Jill Nation Jillian A. Hung José Palacios Joseph H. Rothstein Joseph L. Kelley Jurandyr Moreira de Andrade Luis A. Díaz‐Robles Maria P. Intermaggio Martin Widschwendter Matthias W. Beckmann Matthias Ruebner Mercedes Jimenez‐Liñan Naveena Singh Oleg Oszurek Paul R. Harnett Peter Rambau Hans‐Peter Sinn Philipp Wagner Prafull Ghatage Raghwa Sharma Robert P. Edwards Roberta B. Ness Sandra Oršulić Sara Y. Brucker Sharon E. Johnatty Teri A. Longacre Ursula Eilber Valerie McGuire Weiva Sieh Yanina Natanzon Zheng Li Alice S. Whittemore Anna deFazio Annette Staebler Beth Y. Karlan C. Blake Gilks David D.L. Bowtell Estrid Høgdall Francisco José Cândido dos Reis Helen Steed Ian Campbell Jacek Gronwald Javier Benı́tez Jennifer M. Koziak Jenny Chang‐Claude Kirsten B. Moysich Linda E. Kelemen Linda S. Cook Marc T. Goodman María J. García Peter A. Fasching Stefan Kommoss Suha Deen Susanne K. Kjær Usha Menon James D. Brenton Paul D.P. Pharoah Georgia Chenevix‐Trench David G. Huntsman Stacey J. Winham Martin Köbel Susan J. Ramus

Cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns TILs by histotype and relation to other clinical factors.

10.1001/jamaoncol.2017.3290 article EN JAMA Oncology 2017-10-19

Improved methods are needed to risk stratify and predict outcomes in patients with primary sclerosing cholangitis (PSC). Therefore, we sought derive validate a prediction model compare its performance existing surrogate markers. The was derived using 509 subjects from multicenter North American cohort validated an international (n = 278). Gradient boosting, machine‐based learning technique, used create the model. endpoint hepatic decompensation (ascites, variceal hemorrhage, or...

10.1002/hep.30085 article EN Hepatology 2018-05-09

Altered bile acid (BA) homeostasis is an intrinsic facet of cholestatic liver diseases, but clinical usefulness plasma BA assessment in primary sclerosing cholangitis (PSC) remains understudied. We performed profiling a large retrospective cohort patients with PSC and matched healthy controls, hypothesizing that profiles vary among have utility.Plasma was the Clinical Biochemical Genetics Laboratory at Mayo Clinic using mass spectrometry based assay. Cox proportional hazard (univariate)...

10.1002/hep.31652 article EN Hepatology 2020-11-24
Filipe Correia Martins Dominique‐Laurent Couturier Anna Paterson Anthony N. Karnezis Christine Chow and 92 more Tayyebeh M. Nazeran Adekunle Odunsi Aleksandra Gentry‐Maharaj Aleksandra Vrvilo Alexander Hein Aline Talhouk Ana Osório Andreas D. Hartkopf Angela Brooks‐Wilson Anna deFazio Anna Fischer Arndt Hartmann Brenda Y. Hernandez Bryan M. McCauley Chloe Karpinskyj Christiani Bisinoto de Sousa Claus Høgdall Daniel Guimarães Tiezzi Esther Herpel Florin‐Andrei Taran Francesmary Modugno Gary L. Keeney Gregg Nelson Helen Steed Honglin Song Hugh Luk Javier Benı́tez Jennifer Alsop Jennifer M. Koziak Jenny Lester Joseph H. Rothstein Jurandyr Moreira de Andrade Lene Lundvall Luis Paz‐Ares Luis A. Díaz‐Robles Lynne R. Wilkens María J. García Maria P. Intermaggio Marie-Lyne Alcaraz Mary Anne Brett Matthias W. Beckmann Mercedes Jimenez‐Liñan Michael S. Anglesio Michael E. Carney Michael Schneider Nadia Traficante Nadja Pejovic Naveena Singh Nhu D. Le Hans‐Peter Sinn Prafull Ghatage Ramona Erber Robert P. Edwards Robert A. Vierkant Roberta B. Ness Samuel Leung Sandra Oršulić Sara Y. Brucker Scott H. Kaufmann Sián Fereday Simon A. Gayther Stacey J. Winham Stefan Kommoss Tanja Pejović Teri A. Longacre Valerie McGuire Valerie Rhenius Weiva Sieh Yurii B. Shvetsov Alice S. Whittemore Annette Staebler Beth Y. Karlan Cristina Rodríguez‐Antona David D.L. Bowtell Ellen L. Goode Estrid Høgdall Francisco José Cândido dos Reis Jacek Gronwald Jenny Chang‐Claude Kirsten B. Moysich Linda E. Kelemen Linda S. Cook Marc T. Goodman Peter A. Fasching Robin Crawford Suha Deen Usha Menon David G. Huntsman Martin Köbel Susan J. Ramus Paul D.P. Pharoah James D. Brenton

PTEN loss is a putative driver in histotypes of ovarian cancer (high-grade serous (HGSOC), endometrioid (ENOC), clear cell (CCOC), mucinous (MOC), low-grade (LGSOC)). We aimed to characterise expression as biomarker epithelial large population-based study.

10.1038/s41416-020-0900-0 article EN cc-by British Journal of Cancer 2020-06-17
Martin Köbel Eunyoung Kang Ashley Weir Peter Rambau Cheng‐Han Lee and 95 more Gregg Nelson Prafull Ghatage Nicola S. Meagher Marjorie J. Riggan Jennifer Alsop Michael S. Anglesio Matthias W. Beckmann Christiani Bisinotto M.M. Boisen Jessica Boros Alison H. Brand Angela Brooks‐Wilson Michael E. Carney Penny Coulson Madeleine Courtney‐Brooks Kara L. Cushing‐Haugen Cezary Cybulski Suha Deen Mona El‐Bahrawy Esther Elishaev Ramona Erber Sián Fereday Anna Fischer Simon A. Gayther Arantzazu Barquín Aleksandra Gentry‐Maharaj C. Blake Gilks Helena Gronwald Marcel Grube Paul R. Harnett Holly R. Harris Andreas D. Hartkopf Arndt Hartmann Alexander Hein Joy Hendley Brenda Y. Hernandez Yajue Huang Anna Jakubowska Mercedes Jimenez‐Liñan Michael E. Jones Catherine J. Kennedy Tomasz Kluz Jennifer M. Koziak Jaime Lesnock Jenny Lester Jan Lubiński Teri A. Longacre Maria Lycke Constantina Mateoiu Bryan M. McCauley Valerie McGuire Britta Ney Alexander Olawaiye Sandra Oršulić Ana Osório Luis Paz‐Ares Teresa Ramón y Cajal Joseph H. Rothstein Matthias Ruebner Minouk J. Schoemaker Mitul Shah Raghwa Sharma Mark E. Sherman Yurii B. Shvetsov Naveena Singh Helen Steed Sarah J. Storr Aline Talhouk Nadia Traficante Chen Wang Alice S. Whittemore Martin Widschwendter Lynne R. Wilkens Stacey J. Winham Javier Benı́tez Andrew Berchuck David D.L. Bowtell Francisco José Cândido dos Reis Ian Campbell Linda S. Cook Anna deFazio Jennifer A. Doherty Peter A. Fasching Renée T. Fortner María J. García Marc T. Goodman Ellen L. Goode Jacek Gronwald David G. Huntsman Beth Y. Karlan Linda E. Kelemen Stefan Kommoss Nhu D. Le Stewart G. Martin Usha Menon

Abstract Our objective was to test whether p53 expression status is associated with survival for women diagnosed the most common ovarian carcinoma histotypes (high‐grade serous [HGSC], endometrioid [EC], and clear cell [CCC]) using a large multi‐institutional cohort from Ovarian Tumor Tissue Analysis (OTTA) consortium. assessed on 6,678 cases represented tissue microarrays 25 participating OTTA study sites previously validated immunohistochemical (IHC) assay as surrogate presence functional...

10.1002/cjp2.311 article EN cc-by The Journal of Pathology Clinical Research 2023-03-22

Abstract Background Primary sclerosing cholangitis (PSC) patients have a risk of developing cholangiocarcinoma (CCA). Establishing predictive models for CCA in PSC is important. Methods In large cohort 1,459 seen at Mayo Clinic (1993–2020), we quantified the impact clinical/laboratory variables on development using univariate and multivariate Cox predicted statistical artificial intelligence (AI) approaches. We explored plasma bile acid (BA) levels’ power (subset 300 patients, BA cohort)....

10.1186/s12876-023-02759-7 article EN cc-by BMC Gastroenterology 2023-04-19

Two important questions regarding the genetics of pancreatic adenocarcinoma (PDAC) are 1. Which germline genetic variants influence incidence this cancer; and 2. Whether PDAC causally predisposes to associated non-malignant phenotypes, such as type 2 diabetes (T2D) venous thromboembolism (VTE).

10.1016/j.ebiom.2024.105233 article EN cc-by EBioMedicine 2024-07-12

Abstract Background: Breast cancer (BC) remains a leading health concern worldwide and is often undetected until it metastasizes, limiting treatment options worsening prognosis. Early detection of molecular immune markers in benign breast disease (BBD) could identify women at elevated risk developing invasive, node-positive BC, enabling targeted surveillance prevention efforts. Building on this premise, we investigated the landscape BBD biopsies preceding BC development to enhance...

10.1158/1538-7445.am2025-1912 article EN Cancer Research 2025-04-21

Abstract Introduction: Fibroadenoma is the most common type of benign breast lesion and not traditionally considered an indicator increased cancer risk. This study aimed to identify biomarkers within fibroadenoma associated with subsequent development using patient samples from Mayo Clinic Benign Breast Disease (BBD) cohort. Methods: We analyzed formalin-fixed paraffin-embedded (FFPE) biopsy patients diagnosed non-proliferative who either developed later (n=10) or remained cancer-free (n=5)....

10.1158/1538-7445.am2025-2077 article EN Cancer Research 2025-04-21

Abstract Background: The tumor microenvironment (TME) plays a pivotal role in ovarian cancer (OC) progression and prognosis, while also contributing to biological differences between primary metastatic tumors. This study examines OC TMEs uncover associations with clinical prognosis biology by analyzing paired tumors from the same patients. Methods: focused on 57 stage-IIIC/IV patients treated at Mayo Clinic, all of whom underwent surgical debulking adjuvant therapies. All provided informed...

10.1158/1538-7445.am2025-6266 article EN Cancer Research 2025-04-21

Abstract Introduction: Pseudoangiomatous stromal hyperplasia (PASH) is a benign breast lesion characterized by myofibroblast accumulation. While most women with PASH do not develop cancer, subset eventually does, often in the same where was originally diagnosed, even after surgical removal of lesion. This pattern suggests presence field effect, alterations microenvironment extend beyond itself, potentially influencing neighboring tissue. study aims to identify specific fibroblasts within...

10.1158/1538-7445.am2025-2083 article EN Cancer Research 2025-04-21

Summary To identify novel single nucleotide polymorphisms (SNPs) associated with venous thromboembolism (VTE) in African-Americans (AAs), we performed a genome-wide association study (GWAS) of VTE AAs using the Electronic Medical Records and Genomics (eMERGE) Network, comprised seven sites each DNA biobanks (total ~39,200 unique samples) SNP data (imputed to 1000 Genomes Project cosmopolitan reference panel) linked electronic health records (EHRs). Using validated EHR-driven phenotype...

10.1160/th16-08-0652 article EN Thrombosis and Haemostasis 2017-01-01
Matthew S. Block Robert A. Vierkant Peter Rambau Stacey J. Winham Philipp Wagner and 95 more Nadia Traficante Aleksandra Tołoczko Daniel Guimarães Tiezzi Florin‐Andrei Taran Hans‐Peter Sinn Weiva Sieh Raghwa Sharma Joseph H. Rothstein Teresa Ramón y Cajal Luis Paz‐Ares Oleg Oszurek Sandra Oršulić Roberta B. Ness Gregg Nelson Francesmary Modugno Janusz Menkiszak Valerie McGuire Bryan M. McCauley Marie Mack Jan Lubiński Teri A. Longacre Zheng Li Jenny Lester Catherine J. Kennedy Kimberly R. Kalli Audrey Jung Sharon E. Johnatty Mercedes Jimenez‐Liñan Allan Jensen Maria P. Intermaggio Jillian A. Hung Esther Herpel Brenda Y. Hernandez Andreas D. Hartkopf Paul R. Harnett Prafull Ghatage Jose Maria Garcia-Bueno Bo Gao Sián Fereday Ursula Eilber Robert P. Edwards Christiani Bisinoto de Sousa Jurandyr Moreira de Andrade Anita Chudecka-Głaz Georgia Chenevix‐Trench Alicia Cazorla Sara Y. Brucker Jennifer Alsop Alice S. Whittemore Helen Steed Annette Staebler Kirsten B. Moysich Usha Menon Jennifer M. Koziak Stefan Kommoss Susanne K. Kjær Linda E. Kelemen Beth Y. Karlan David G. Huntsman Estrid Høgdall Jacek Gronwald Marc T. Goodman C. Blake Gilks María J. García Peter A. Fasching Anna de Fazio Suha Deen Jenny Chang‐Claude Francisco José Cândido dos Reis Ian Campbell James D. Brenton David D.L. Bowtell Javier Benı́tez Paul D.P. Pharoah Martin Köbel Susan J. Ramus Ellen L. Goode David D.L. Bowtell Georgia Chenevix‐Trench A. Green Penelope M. Webb Anna deFazio Dorota M. Gertig Nadia Traficante Sián Fereday S. Moore Jillian A. Hung K.R. Harrap T. Sadkowsky Nirmala Pandeya M. Malt A. Mellon R. Paul Robertson T. Vanden Bergh Marsha Jones

ObjectiveTo evaluate myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 (TLR4) expression in relation to clinical features of epithelial ovarian cancer, histologic subtypes, overall survival.Patients MethodsWe conducted centralized immunohistochemical staining, semi-quantitative scoring, survival analysis 5263 patients participating the Ovarian Tumor Tissue Analysis consortium. Patients were diagnosed between January 1, 1978, December 31, 2014, including 2865...

10.1016/j.mayocp.2017.10.023 article EN cc-by-nc-nd Mayo Clinic Proceedings 2018-03-01

Abstract Background & Aims Primary biliary cirrhosis ( PBC ) is characterized by chronic cholestasis and disease‐specific antimitochondrial antibodies AMA ). A high prevalence of s in first‐degree relatives FDR s) probands has been reported, although the natural history such patients not described. We aimed to assess risk developing + with . Methods First‐degree recruited Mayo Clinic Genetic Epidemiology Registry Biorepository were followed for disease onset after recruitment....

10.1111/liv.13143 article EN Liver International 2016-04-10

Abstract Background: Ovarian clear cell carcinoma (OCCC) is a rare ovarian cancer histotype that tends to be resistant standard platinum-based chemotherapeutics. We sought better understand the role of DNA methylation in clinical and biological subclassification OCCC. Methods: interrogated genome-wide using from fresh frozen tumors 271 cases, applied nonsmooth nonnegative matrix factorization (nsNMF) clustering, evaluated associations pathways. Results: Two approximately equally sized...

10.1158/1055-9965.epi-21-0677 article EN cc-by Cancer Epidemiology Biomarkers & Prevention 2021-10-25

Primary sclerosing cholangitis (PSC) typically develops in middle-age adults. Little is known about phenotypic differences when PSC diagnosed at various ages. Therefore, we sought to compare the clinical characteristics of a large cohort based on age was diagnosed.We performed multicenter retrospective review features among those between 1-19 (n = 95), 20-59 662), and 60-79 years 102).Those with an early diagnosis (ED) were more likely have small-duct (13%) than (MD) (5%) late (LD) groups...

10.1111/jgh.13774 article EN Journal of Gastroenterology and Hepatology 2017-03-01

Failure of immunologic homeostasis and resultant hepatocyte destruction in autoimmune hepatitis (AIH) is likely the result environmental triggers within a permissive genetic architecture.We aimed to identify risk factors associated with AIH well-phenotyped cohort.We prospectively collected questionnaires from 358 cases 563 healthy controls. Response frequencies were compared using logistic regression, adjusting for age at recruitment, sex education.AIH more ever have urinary tract infection...

10.1111/liv.14944 article EN Liver International 2021-05-12

Background: The epigenome, the set of modifications to DNA and associated molecules that control gene expression, cellular identity, function, plays a major role in mediating responses outside factors. Thus, evaluation epigenetic state can provide insights into adaptions occurring over course disease. Methods: We performed epigenome-wide association studies primary sclerosing cholangitis (PSC) biliary (PBC) using Illumina MethylationEPIC Bead Chip. Results: found evidence increased age...

10.1097/hc9.0000000000000496 article EN cc-by-nc-nd Hepatology Communications 2024-07-18

Abstract Background: Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no outcome at genome-wide levels significance. Methods: We carried out a association study (GWAS) PFS 2,352 women EOC who had undergone cytoreductive surgery and standard carboplatin/paclitaxel chemotherapy. Results: seven SNPs 12q24.33 (P < 5 × 10–8), the top SNP being rs10794418 (HR = 1.24;...

10.1158/1055-9965.epi-20-1817 article EN Cancer Epidemiology Biomarkers & Prevention 2021-06-23

Abstract Background Benign breast disease (BBD) increases cancer (BC) risk progressively for women diagnosed with non-proliferative (NP) change, proliferative without atypia (PDWA), and atypical hyperplasia (AH). Leveraging data from 18,704 in the Mayo BBD Cohort (1967-2013), we evaluated temporal trends diagnoses how they have influenced associated BC over four decades. Methods were using standardized incidence ratios (SIRs) age-period-cohort modeling across eras—pre-mammogram (1967-1981),...

10.1093/jncics/pkae128 article EN cc-by-nc-nd JNCI Cancer Spectrum 2024-12-23
Coming Soon ...